Clinical Trials in San Francisco

Showing 1941-1960 of 6,211 trials

A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot

NCT04564443

The purpose of this clinical investigation is to assess performance of the Medaxis Debritom+™ and to collect subject outcome data in the treatment of diabetic foot ulcers (DFU) vs Standard sharp debridement.

Diabetic Foot UlcerDiabetic Foot

Medaxis, LLC222 participantsStarted Sep 2020

San Francisco, California, United States • South Miami, Florida, United States • Frederick, Maryland, United States +3 more locations

Enrolling By InvitationNA< 1 mile

Electrical Stimulation of the Optic Nerve in Patients With Glaucoma.

NCT06693882

The goal of this observational study is to evaluate electrical stimulation of the optic nerve with the Eyetronic Nextwave System device as a possible treatment for glaucoma. The main question it aims to answer is: Could this therapy be an option to counteract the loss of visual field seen in glaucoma and thus delay the progression of the disease? Participants will have approximately 14-18 study visits during 12 months including 10 visits for the electrical stimulation treatment. The treatment involves electrically stimulating the optic nerve by an external approach via the facial skin.

Glaucoma

Glaucoma Center of San Francisco50 participantsStarted Jan 2025

San Francisco, California, United States

A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot

Electrical Stimulation of the Optic Nerve in Patients With Glaucoma.

Find Trials by Condition in San Francisco

A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

Myotonic Dystrophy Family Registry

A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment

Validity of AI in Treatment of the Musculoskeletal Conditions by Vifive

Texting to Reduce Alcohol Misuse Pilot Trial

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy

A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.

Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.